Babson Diagnostics and Pharmacy Podcast Network Announce Partnership That Will Take Listeners Inside Largest Retail Pharmacy Trade Show

Babson to host popular podcast from its booth at the Total Store Expo AUSTIN, Texas–(BUSINESS WIRE)–#BloodTesting–Babson Diagnostics, a science-first, health care technology company, today announced a media partnership with the Pharmacy Podcast Network in connection with the 2022 National Association of Chain Drug Stores’ Total Store Expo, the largest gathering of retailers and suppliers in … [Read more…]

LifeWorks releases the results of its Performance Universe of Pension Managers’ Pooled Funds

Pension funds post sharp declines in the second quarter of 2022 TORONTO–(BUSINESS WIRE)–LifeWorks (TSX: LWRK) has released the results of its Performance Universe of Pension Managers’ Pooled Funds for the second quarter of 2022. According to the report, in the second quarter of 2022, diversified pooled fund managers posted a median return of negative 9.4 … [Read more…]

Affini-T Therapeutics Appoints Pioneering T Cell Therapy and KRAS Developer Dirk Nagorsen, M.D., as Chief Medical Officer

Dr. Nagorsen brings over two decades of leadership in oncology, most recently at Amgen where he led the early development of Lumakras® and Blincyto® BOSTON & SEATTLE–(BUSINESS WIRE)–Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, today announced the appointment of Dirk Nagorsen, M.D., as the company’s Chief … [Read more…]

Published UCLA and Spectrum Solutions Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers

SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions, LLC today announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry. The project has successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva. Specifically, amplified EGFR mutations associated with … [Read more…]

ADM Reports Second Quarter Earnings per Share of $2.18, $2.15 on an Adjusted Basis

Net earnings and adjusted earnings of about $1.2 billion Adjusted ROIC of 11.6% CHICAGO–(BUSINESS WIRE)–ADM (NYSE: ADM) today reported financial results for the quarter ended June 30, 2022. “Our second quarter adjusted earnings per share of $2.15 reflect our team’s strong execution, delivering nutrition to billions of people around the globe,” said Chairman and CEO … [Read more…]

Carmot Therapeutics closes $160 million Series D financing to advance clinical pipeline of novel incretin receptor modulators

BERKELEY, Calif.–(BUSINESS WIRE)–Carmot Therapeutics, Inc., a clinical-stage biotechnology company applying its proprietary drug discovery platform, Chemotype Evolution, to discover and develop disease-modifying therapies in metabolic disease and cancer, announced today a $160 million Series D financing. The funding will support the completion of phase 2 studies for CT-388, a once weekly, dual modulator of the … [Read more…]

Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures

LEWISVILLE, TEXAS–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the limited market release and first patient implant of the Virtuos™ Lyograft, a first-of-its-kind, shelf-stable and complete autograft substitute for spine and orthopedic procedures. This allograft is prepared by MTF Biologics through a proprietary process that … [Read more…]

Generate Biomedicines Expands Leadership Team with the Addition of Chief Medical Officer Alexandra Snyder, M.D.

Dr. Snyder brings robust clinical development expertise from Two River and Merck & Co., Inc. SOMERVILLE, Mass.–(BUSINESS WIRE)–Generate Biomedicines, whose machine learning-powered generative biology platform can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics, today announced that Alexandra Snyder, M.D. has been named Chief Medical Officer to … [Read more…]

Head and Neck Cancer Diagnostics Market – Global Industry Analysis, Trends, and Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Head and Neck Cancer Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global head and neck cancer diagnostics market to grow with a CAGR of 11% over the forecast period from 2022-2028. The report on the global … [Read more…]

Alzheon to Present Industry-Leading Phase 2 Biomarker and Clinical Data with ALZ-801 (Valiltramiprosate) Oral Tablet at 2022 Alzheimer’s Association International Conference

New Results Position ALZ-801 to Potentially Become the First Oral Agent that Can Slow or Even Stop and Prevent Alzheimer’s Pathology in Patients and Healthy Individuals at Risk for the Disease Several-Fold Greater Reduction on P-tau181 Compared to Anti-Amyloid Antibodies Validates Superior Clinical Benefit from Prior Studies in Alzheimer’s Patients Significant Improvement on Memory Tests … [Read more…]